North America Musculoskeletal (MSK) Disease Management Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2032

North America Musculoskeletal (MSK) Disease Management Market Size

• The North America musculoskeletal (MSK) disease management market size was valued at USD 6.15 billion in 2024 and is expected to reach USD 32.25 billion by 2032, at a CAGR of 23.0% during the forecast period
• The market growth is largely fueled by the increasing prevalence of musculoskeletal disorders, aging populations, and rising awareness about early diagnosis and effective disease management. Technological advancements in treatment options, including minimally invasive procedures, regenerative therapies, and digital health monitoring tools, are further driving market expansion
• Furthermore, growing demand from hospitals, rehabilitation centers, and orthopedic clinics for comprehensive MSK disease management solutions is establishing these therapies and services as essential components of patient care. These converging factors are accelerating the adoption of advanced Musculoskeletal (MSK) Disease Management solutions, thereby significantly boosting the growth of the market across diagnostic, therapeutic, and rehabilitation applications

North America Musculoskeletal (MSK) Disease Management Market Analysis

• The Musculoskeletal (MSK) Disease Management market is increasingly vital in modern healthcare systems due to the growing prevalence of musculoskeletal disorders, rising geriatric population, and increasing adoption of advanced diagnostic, therapeutic, and rehabilitation solutions in both clinical and outpatient settings
• The escalating demand for MSK disease management solutions is primarily fueled by the rising incidence of orthopedic conditions, sports-related injuries, osteoarthritis, and chronic pain, coupled with growing awareness about preventive care, minimally invasive procedures, and rehabilitation programs
• U.S. dominated the musculoskeletal (MSK) disease management market within North America with the largest revenue share of 90.8% in 2024, supported by advanced healthcare infrastructure, high surgical volumes, early adoption of minimally invasive and robotic-assisted techniques, and the presence of leading medical device manufacturers. The country leads in the adoption of image-guided procedures, advanced rehabilitation technologies, and AI-driven clinical decision support, which are driving significant improvements in patient outcomes and fueling market growth
• Canada is expected to be the fastest-growing country in the musculoskeletal (MSK) disease management market during the forecast period, projected to expand at a CAGR of 11.2% from 2025 to 2032. This growth is attributed to increasing government investments in healthcare modernization, rising adoption of minimally invasive surgeries, and expanding access to orthopedic care across both urban and rural regions. In addition, the country’s growing emphasis on early diagnosis, preventive care, and integration of digital rehabilitation platforms is boosting demand for MSK disease management solutions
• The Adults segment dominated North America musculoskeletal (MSK) disease management market with a share of 46.7% in 2024, due to the high prevalence of musculoskeletal conditions such as back pain, sports injuries, and osteoarthritis in this population

Report Scope and Musculoskeletal (MSK) Disease Management Market Segmentation      

North America Musculoskeletal (MSK) Disease Management Market Trends

Enhanced Efficiency and Integration in Musculoskeletal Care

• A significant and accelerating trend in the North America musculoskeletal (MSK) disease management market is the deepening integration of advanced diagnostic, therapeutic, and rehabilitation technologies. This convergence of tools and approaches is significantly enhancing clinical efficiency, patient monitoring, and personalized treatment outcomes
  • For instance, modern MSK management solutions increasingly combine real-time imaging, computer-assisted surgical planning, and data-driven rehabilitation programs, enabling clinicians to optimize patient care from diagnosis to recovery. Hospitals and specialty clinics are adopting integrated platforms that track patient progress, adjust therapy plans, and provide detailed insights for both short-term and long-term musculoskeletal health
• The integration of minimally invasive surgical techniques with advanced rehabilitation technologies allows for faster recovery, reduced hospital stays, and improved functional outcomes. For instance, robotic-assisted orthopedic surgery combined with targeted physiotherapy protocols enables more precise interventions and tailored post-operative care for patients with fractures, osteoarthritis, or ligament injuries
• Centralized patient management systems are becoming increasingly prevalent, allowing healthcare providers to consolidate diagnostic results, surgical data, and rehabilitation progress into a unified digital framework. This integration enhances coordination among multidisciplinary teams and ensures that treatment is consistent, efficient, and evidence-based
• The trend toward more comprehensive, data-driven, and patient-centric musculoskeletal care is fundamentally reshaping clinical practices and expectations. Consequently, companies and healthcare providers are developing integrated MSK management platforms that streamline care pathways, improve surgical accuracy, and enable continuous monitoring of patient outcomes
• The demand for solutions that offer seamless integration across diagnostics, treatment, and rehabilitation is growing rapidly across both hospital and outpatient care settings, as patients and providers increasingly prioritize personalized, effective, and efficient musculoskeletal healthcare

North America Musculoskeletal (MSK) Disease Management Market Dynamics

Driver

Growing Need Due to Rising Prevalence of Musculoskeletal Disorders

• The increasing prevalence of musculoskeletal disorders, coupled with rising awareness about preventive care and rehabilitation solutions, is a significant driver for the heightened demand for Musculoskeletal (MSK) Disease Management solutions
  • For instance, in April 2024, several healthcare providers in the U.S. announced the adoption of integrated MSK management platforms combining advanced imaging, robotic-assisted surgery, and post-operative rehabilitation programs. Such strategies by key companies are expected to drive the musculoskeletal (MSK) disease management industry growth in the forecast period
• As patients and healthcare providers become more aware of the long-term impact of musculoskeletal conditions, comprehensive MSK solutions offer advanced features such as early diagnosis, personalized treatment planning, and continuous monitoring, providing a compelling improvement over traditional therapy
• Furthermore, the growing adoption of digital rehabilitation platforms and telehealth-based physiotherapy programs are making MSK disease management more accessible and efficient, offering seamless integration across hospitals, clinics, and home care settings
• The convenience of coordinated care pathways, structured rehabilitation programs, and remote monitoring of patient progress are key factors propelling the adoption of MSK management solutions in both hospital and outpatient sectors. The trend towards multidisciplinary care models and the increasing availability of evidence-based, patient-centric MSK solutions further contribute to market growth

Restraint/Challenge

High Treatment Costs and Limited Awareness in Emerging Regions

• Concerns surrounding the high costs of advanced MSK management systems, including robotic-assisted surgery, imaging-guided interventions, and personalized rehabilitation programs, pose a significant challenge to broader market penetration. As advanced MSK solutions involve substantial investment in infrastructure and training, they can be less accessible to price-sensitive healthcare providers and patients, particularly in developing regions
  • For instance, high treatment costs and limited awareness about comprehensive MSK care in emerging markets have delayed the adoption of these solutions in certain regions
• Addressing these challenges through cost-effective solutions, government initiatives for musculoskeletal health, and training programs for healthcare professionals is crucial for expanding market access. Companies and providers are emphasizing affordable and modular MSK solutions, along with patient education campaigns, to reassure potential adopters
• While costs are gradually decreasing with technological advancements and local manufacturing, the perceived premium for advanced MSK care can still hinder widespread adoption, especially for patients and facilities not requiring high-end interventions
• Overcoming these challenges through affordable care models, awareness programs, and scalable MSK management solutions will be vital for sustained market growth

North America Musculoskeletal (MSK) Disease Management Market Scope

The market is segmented on the basis of type, technology, integration type, modality, application, patient population, and end-user.

• By Type

On the basis of type, the musculoskeletal (MSK) disease management market is segmented into digital biofeedback systems, musculoskeletal-focused digital apps, solutions, and others. The digital biofeedback systems segment dominated the largest market revenue share of 38.6% in 2024, driven by its ability to provide real-time feedback on muscle activity and movement patterns, which helps clinicians tailor rehabilitation programs precisely for each patient. This system enhances treatment effectiveness and accelerates recovery, making it a preferred solution in hospitals, clinics, and virtual care settings. Integration with wearable sensors and advanced monitoring platforms allows continuous patient tracking, improving adherence to therapy regimens. Its ability to capture detailed data for outcome assessment supports clinical decision-making. Furthermore, Digital Biofeedback Systems are widely used in post-surgery rehabilitation and chronic condition management, which adds to their dominance. The segment’s robust adoption is also fueled by its compatibility with both in-person and remote therapy programs.

The musculoskeletal-focused digital apps segment is expected to witness the fastest CAGR of 22.1% from 2025 to 2032, supported by the increasing demand for accessible, interactive, and home-based rehabilitation programs. These apps guide patients through structured exercises, track progress, and allow therapists to monitor adherence remotely. Gamification features improve patient engagement, while analytics provide insights for personalized therapy adjustments. Low deployment costs and wide accessibility make these apps particularly attractive for outpatient care and telehealth services. The apps are also being increasingly integrated with wearable devices and cloud-based platforms, enhancing their functionality. Their scalability across different patient populations, including adults and geriatrics, contributes to rapid adoption. In addition, the growing trend of digital health and virtual care supports the segment’s significant growth trajectory.

• By Technology

On the basis of technology, the musculoskeletal (MSK) disease management market is segmented into precision motion technology, computer vision technology, and other technologies. The precision motion technology segment dominated with a market share of 41.3% in 2024, as it enables highly accurate measurement of joint angles, muscle activation, and motion patterns during rehabilitation. This technology allows clinicians to create personalized therapy plans based on precise biomechanical data. Hospitals and rehabilitation centers leverage Precision Motion Technology for post-surgical recovery, chronic pain management, and injury prevention. Integration with wearable sensors and telehealth platforms ensures continuous monitoring, real-time feedback, and improved treatment outcomes. Its adoption is also driven by the rising emphasis on data-driven rehabilitation and patient-centered care. Moreover, precision tracking facilitates performance evaluation and outcome reporting, which is critical for healthcare providers and insurers.

The computer vision technology segment is anticipated to record the fastest CAGR of 19.7% from 2025 to 2032, driven by non-invasive, marker less motion tracking capabilities. Computer vision allows remote assessment of patient movements without the need for specialized sensors, making virtual therapy sessions more effective and convenient. It enhances patient engagement through real-time visual feedback and performance monitoring. Integration with digital therapy platforms allows therapists to remotely adjust treatment plans and track progress efficiently. The technology is increasingly adopted in home rehabilitation programs, outpatient centers, and telehealth solutions. Its rapid development is supported by AI-assisted motion analysis and machine learning algorithms, which improve accuracy and predictive insights. As a result, this segment is set for significant growth in the MSK market.

• By Integration Type

On the basis of integration type, the musculoskeletal (MSK) disease management market is segmented into phone, tablet, computer, and others. The phone segment dominated with a market share of 36.5% in 2024, due to its widespread use as the primary interface for digital rehabilitation and MSK-focused apps. Smartphones offer portability, seamless connectivity, and user-friendly interfaces that allow patients to engage with therapy programs anytime and anywhere. Integration with wearable sensors and cloud platforms provides clinicians with real-time access to patient data, enhancing remote monitoring and treatment effectiveness. Phones also facilitate interactive guidance, progress tracking, and alerts for adherence, increasing the likelihood of positive outcomes. Their accessibility makes them suitable for all patient populations, including adults and geriatrics. In addition, smartphones support telehealth platforms, expanding care delivery beyond traditional clinical settings.

The tablet segment is expected to witness the fastest CAGR of 21.4% from 2025 to 2032, supported by larger display sizes, interactive touch interfaces, and enhanced visualization for guided therapy sessions. Tablets allow detailed visual instructions, immersive exercise demonstrations, and real-time feedback, which improves therapy adherence and effectiveness. They are particularly favored in clinics and home care settings for patients requiring more detailed monitoring and engagement. Integration with virtual therapy platforms and biofeedback systems enhances their utility for both pre- and post-surgical applications. The tablets’ ease of use for elderly patients and the ability to connect multiple users simultaneously further accelerates adoption. Their compatibility with advanced analytics platforms also supports clinicians in adjusting treatment plans dynamically.

• By Modality

On the basis of modality, the musculoskeletal (MSK) disease management market is segmented into virtual therapy, in-person therapy, customized/personalized therapy, and others. The in-person therapy segment dominated with a market share of 42.8% in 2024, owing to the critical need for hands-on guidance from trained therapists during complex rehabilitation sessions. In-person therapy ensures correct exercise execution, immediate feedback, and reduces the risk of complications, which is particularly important post-surgery. Hospitals and clinics prefer this modality for high-risk patients, while integrating digital monitoring solutions to enhance outcomes. Its effectiveness in restoring mobility, reducing pain, and accelerating recovery solidifies its dominant position. In-person sessions also facilitate personalized adjustments in therapy intensity and duration, improving patient satisfaction and clinical results.

The virtual therapy segment is projected to witness the fastest CAGR of 20.3% from 2025 to 2032, driven by tele-rehabilitation solutions, remote monitoring technologies, and patient preference for home-based care. Virtual therapy allows patients to perform guided exercises with real-time clinician feedback without visiting a clinic. The modality enhances accessibility, reduces travel time, and ensures continuity of care. Integration with motion tracking, AI analytics, and interactive apps further enhances engagement and treatment effectiveness. Its adoption is fueled by the rising trend of digital health, increasing comfort with technology, and demand for cost-effective rehabilitation. Virtual therapy is especially advantageous for patients in rural areas or with mobility constraints.

• By Application

On the basis of application, the musculoskeletal (MSK) disease management market is segmented into pre-surgery applications and post-surgery applications. The post-surgery applications segment dominated with a market share of 44.1% in 2024, driven by the need for structured rehabilitation programs after orthopedic surgeries. Post-surgery therapy ensures faster recovery, reduces complications, and restores functional mobility. Hospitals and clinics deploy advanced MSK solutions to monitor patient adherence, track recovery metrics, and customize interventions. Integration with digital platforms and wearable sensors supports continuous monitoring, providing data-driven insights to clinicians. The growing number of joint replacement surgeries and orthopedic interventions globally also fuels demand. Post-surgery applications improve patient outcomes, reduce hospital readmissions, and enhance quality of life, reinforcing their market leadership.

The Pre-Surgery Applications segment is expected to witness the fastest CAGR of 18.5% from 2025 to 2032, supported by prehabilitation programs aimed at improving patient strength, flexibility, and resilience prior to surgery. Pre-surgery interventions help reduce operative risks, accelerate post-operative recovery, and improve overall surgical outcomes. Integration with digital apps and remote monitoring tools ensures patient engagement and adherence to exercise protocols. Rising awareness of prehabilitation benefits among healthcare providers and patients is driving adoption. The segment also benefits from the increasing number of elective orthopedic surgeries and preventive care initiatives globally.

• By Patient Population

On the basis of patient population, the musculoskeletal (MSK) disease management market is segmented into pediatrics, adults, and geriatrics. The adults segment dominated with a market share of 46.7% in 2024, primarily due to the widespread prevalence of musculoskeletal conditions such as chronic back pain, sports-related injuries, and osteoarthritis within this group. Adults represent the largest consumer base for both traditional in-person rehabilitation and rapidly expanding digital MSK therapy solutions. Their greater familiarity with and reliance on technology-based interventions, such as telehealth and app-driven programs, has further strengthened their market dominance. Additionally, workplace wellness initiatives targeting employees, increasing use of prehabilitation programs to prepare for surgeries, and structured post-surgery rehabilitation services significantly contribute to demand in this segment. The ability of adults to actively engage in and adhere to comprehensive treatment plans also supports the sustained growth of this population in the market.

The geriatrics segment is projected to witness the fastest CAGR of 21.0% from 2025 to 2032, supported by the accelerating pace of global population aging and rising healthcare needs of older adults. Elderly patients are at higher risk of musculoskeletal disorders such as osteoporosis, arthritis, and mobility impairments, driving demand for specialized MSK care. Tailored programs focusing on fall prevention, mobility enhancement, and post-operative rehabilitation are increasingly being adopted to improve health outcomes and quality of life among this group. Furthermore, home-based and tele-rehabilitation options are gaining traction as they provide accessible, continuous, and cost-effective care for seniors with limited mobility or transportation barriers. Increased awareness of age-related MSK conditions, combined with government and healthcare initiatives promoting healthy aging, further propels the adoption of geriatric-focused solutions across the market.

• By End-User

On the basis of end-user, the musculoskeletal (MSK) disease management market is segmented into hospitals & clinics, nursing homes, health centers, rehabilitation centres, virtual/home health care settings, and others. The hospitals & clinics segment dominated with a market share of 48.2% in 2024, driven by their role as central hubs for diagnosis, treatment, and rehabilitation of complex musculoskeletal conditions. Hospitals and clinics are equipped with advanced therapy equipment, access to trained professionals, and seamless integration with surgical and diagnostic services, making them the primary choice for comprehensive MSK care. Post-surgical patients frequently rely on hospital-based rehabilitation programs, and the growing adoption of hybrid models combining in-person therapy with digital monitoring tools has further enhanced their market share. The ability of hospitals to cater to both acute and chronic MSK cases, along with specialized multidisciplinary teams, ensures consistent patient demand in this segment.

The virtual/home health care settings segment is expected to witness the fastest CAGR of 23.4% from 2025 to 2032, propelled by the increasing adoption of telehealth platforms and remote rehabilitation technologies. Patients are increasingly drawn to the convenience of receiving MSK care at home, particularly those with mobility challenges, post-surgical recovery needs, or living in remote locations with limited access to healthcare facilities. The integration of wearable devices, motion sensors, and AI-enabled platforms allows real-time monitoring of patient progress, enabling healthcare providers to personalize treatment plans and make timely adjustments. Home-based care also enhances patient adherence, reduces hospital visits, and lowers overall treatment costs, making it a highly attractive alternative. The rising preference for patient-centric and flexible rehabilitation solutions continues to accelerate growth in this segment, positioning it as the most dynamic contributor to future market expansion

North America Musculoskeletal (MSK) Disease Management Market Regional Analysis

• North America dominated the musculoskeletal (MSK) disease management market with the largest revenue share of 30.4% in 2024, supported by advanced healthcare infrastructure, high surgical volumes, early adoption of minimally invasive techniques, and a strong presence of key medical device manufacturers
• The region benefits from well-established hospitals, skilled medical professionals, and widespread access to advanced rehabilitation technologies
• The availability of robotic-assisted surgery, image-guided procedures, and integrated post-operative care solutions further drives the demand for MSK disease management systems

U.S. Musculoskeletal (MSK) Disease Management Market Insight

The U.S. musculoskeletal (MSK) disease management market captured the largest revenue share of 90.8% within North America in 2024, fueled by high adoption of robotic-assisted orthopedic surgeries, advanced imaging technologies, and integrated rehabilitation programs. Hospitals and clinics are increasingly implementing personalized therapy solutions, digital biofeedback systems, and tele-rehabilitation platforms. The strong focus on improving surgical outcomes, reducing recovery times, and enhancing patient quality of life underpins market growth. Government support for healthcare modernization and ongoing investments in clinical infrastructure also bolster expansion.

Canada Musculoskeletal (MSK) Disease Management Market Insight

The Canada musculoskeletal (MSK) disease management market is expected to be the fastest-growing within North America during the forecast period, projected to expand at a CAGR of 11.2% from 2025 to 2032. Growth is being accelerated by significant government investments in healthcare modernization and increasing adoption of minimally invasive and robotic-assisted surgical techniques across orthopedic care. Expanding access to specialized MSK treatment services in both urban and rural regions is further strengthening market development. In addition, Canada’s growing focus on preventive care, early diagnosis of musculoskeletal disorders, and integration of digital rehabilitation platforms is reshaping patient management pathways. The rising uptake of tele-rehabilitation, wearable-based monitoring, and AI-enabled therapy support tools is enhancing accessibility and patient engagement. Collectively, these advancements are positioning Canada as the fastest-growing market for MSK disease management solutions in North America.

Musculoskeletal (MSK) Disease Management Market Share

The musculoskeletal (MSK) disease management industry is primarily led by well-established companies, including:

• RecoveryOne (U.S.)
• Omada Health Inc. (U.S.)
• DarioHealth Corp. (U.S.)
• Included Health, Inc. (U.S.)
• Kaia Health (U.S.)
• International Marketing Corporation Pvt. Ltd. (U.S.)
• Movement RX (U.S.)
• Phzio (Canada)
• Airrosti Rehab Center, LLC (U.S.)
• SimpleTherapy, Inc. (U.S.)
• Hinge Health, Inc. (U.S.)
• Sword Health, Inc. (Portugal)
• SPRITE HEALTH (U.S.)
• Limber Health, Inc. (U.S.)

Latest Developments in North America Musculoskeletal (MSK) Disease Management Market

• In April 2022, Airrosti Rehab Center, LLC formed a partnership with Buoy Health’s innovative healthcare marketplace. The partnership resulted to bring good value MSK care to Buoy’s more than 2 million users per month and the development of novel MSK virtual products
• In March 2022, DarioHealth Corp. formed a contractual agreement with Sanofi U.S. The agreement focused on the acceleration of commercial growth for DarioHealth Corp. in MSK disease management digital portfolio and the development of Digital Health Solutions on the DarioHealth Corp. platform
• In December 2024, TailorCare acquired RecoveryOne to revolutionize musculoskeletal care. TailorCare, a leading provider of specialty value-based care solutions, announced the acquisition of RecoveryOne, a virtual physical therapy platform focused on musculoskeletal (MSK) recovery. This strategic acquisition enhances TailorCare’s capabilities, creating a comprehensive MSK offering for patients, and better serving the needs of payers and providers
• In May 2023, Sword Health launched its platform to predict, prevent, and treat pain. Sword Health, the world’s fastest-growing pain solution, announced the launch of its platform to predict, prevent, and treat pain. With its products now used by members of more than 2,500 companies across three continents, Sword is turning everything it has learned about making optimal clinical-grade treatments more accessible into a single platform that can help people avoid and treat the pain that afflicts 60% of adults each year according to the CDC

SKU-69485